Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis.

[1]  Lenka Murgasova,et al.  Implantation eines Trachealstents bei erwachsenem Patienten mit Morbus Hunter , 2020, Laryngo-Rhino-Otologie.

[2]  A. Hlavatá,et al.  Genotype–phenotype correlation in 44 Czech, Slovak, Croatian and Serbian patients with mucopolysaccharidosis type II , 2017, Clinical genetics.

[3]  R. Huth,et al.  Management of Life-Threatening Tracheal Stenosis and Tracheomalacia in Patients with Mucopolysaccharidoses. , 2016, JIMD reports.

[4]  R. Huber,et al.  Tracheobronchial stents in mucopolysaccharidosis. , 2016, International journal of pediatric otorhinolaryngology.

[5]  Carlene Campbell,et al.  Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri. , 2015, The Journal of pediatrics.

[6]  T. Coşkun,et al.  Mucopolysaccharidosis: Otolaryngologic findings, obstructive sleep apnea and accumulation of glucosaminoglycans in lymphatic tissue of the upper airway. , 2014, International journal of pediatric otorhinolaryngology.

[7]  C. Giaquinto,et al.  Incidence and clinical presentation of acute otitis media in children aged <6 years in European medical practices , 2013, Epidemiology and Infection.

[8]  E. Cantone,et al.  Management of otolaryngological manifestations in mucopolysaccharidoses: our experience , 2013, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[9]  J. Muenzer,et al.  Bronchoscopy and airway management in patients with mucopolysaccharidoses (MPS) , 2013, Pediatric pulmonology.

[10]  I. Bruce,et al.  Anaesthesia and airway management in mucopolysaccharidosis , 2012, Journal of Inherited Metabolic Disease.

[11]  A. Keilmann,et al.  Hearing loss in patients with mucopolysaccharidosis II: Data from HOS – the Hunter Outcome Survey , 2012, Journal of Inherited Metabolic Disease.

[12]  J. Muenzer.  Overview of the mucopolysaccharidoses. , 2011, Rheumatology.

[13]  J. Muenzer,et al.  Respiratory manifestations in mucopolysaccharidoses. , 2011, Paediatric respiratory reviews.

[14]  A. Şanlı,et al.  Prevalence of Otitis Media with Effusion Among Primary School Age-Children and Etiopathogenic Examination , 2011, Indian Journal of Otolaryngology and Head & Neck Surgery.

[15]  B. Burton,et al.  Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): Data from the Hunter Outcome Survey , 2010, Genetics in Medicine.

[16]  M. Elleder,et al.  The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations , 2010, Journal of Inherited Metabolic Disease.

[17]  V. Proud,et al.  Role of the pediatric otolaryngologist in diagnosis and management of children with mucopolysaccharidoses. , 2010, International journal of pediatric otorhinolaryngology.

[18]  C. Eng,et al.  Multidisciplinary Management of Hunter Syndrome , 2009, Pediatrics.

[19]  I. Bruce,et al.  Otorhinolaryngological manifestations of the mucopolysaccharidoses. , 2005, International journal of pediatric otorhinolaryngology.

[20]  O. Amaral,et al.  Prevalence of lysosomal storage diseases in Portugal , 2004, European Journal of Human Genetics.

[21]  A. Parving.  Hearing screening--aspects of epidemiology and identification of hearing impaired children. , 1999, International journal of pediatric otorhinolaryngology.

[22]  C. V. van Hasselt,et al.  Prevalence of otitis media with effusion in multicultural schools in Hong Kong , 1997, The Journal of Laryngology & Otology.

[23]  K. Steel,et al.  A histologic study of nonmorphogenetic forms of hereditary hearing impairment. , 1992, Archives of otolaryngology--head & neck surgery.

[24]  R. Watts,et al.  Histopathological studies of the temporal bones in Hurler's disease [Mucopolysaccharidosis (MPS) IH] , 1985, The Journal of Laryngology & Otology.